vs
Side-by-side financial comparison of BELDEN INC. (BDC) and Dexcom (DXCM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $696.4M, roughly 1.8× BELDEN INC.). Dexcom runs the higher net margin — 21.2% vs 7.3%, a 13.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 11.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 7.3%).
Belden Inc. is an American, multinational, publicly traded company specializing in the design, manufacture, and distribution of end-to-end networking, security and connectivity products. The company serves the Industrial Automation Solutions, Smart Buildings and Broadband & 5G markets.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
BDC vs DXCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $696.4M | $1.3B |
| Net Profit | $51.0M | $267.3M |
| Gross Margin | 37.1% | 62.9% |
| Operating Margin | 11.2% | 25.6% |
| Net Margin | 7.3% | 21.2% |
| Revenue YoY | 11.4% | 21.6% |
| Net Profit YoY | -1.8% | 153.6% |
| EPS (diluted) | $1.30 | $0.67 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $696.4M | $1.3B | ||
| Q4 25 | $720.1M | $1.3B | ||
| Q3 25 | $698.2M | $1.2B | ||
| Q2 25 | $672.0M | $1.2B | ||
| Q1 25 | $624.9M | $1.0B | ||
| Q4 24 | $666.0M | $1.1B | ||
| Q3 24 | $654.9M | $994.2M | ||
| Q2 24 | $604.3M | $1.0B |
| Q1 26 | $51.0M | $267.3M | ||
| Q4 25 | $67.9M | $267.3M | ||
| Q3 25 | $56.7M | $283.8M | ||
| Q2 25 | $61.0M | $179.8M | ||
| Q1 25 | $51.9M | $105.4M | ||
| Q4 24 | $58.4M | $151.7M | ||
| Q3 24 | $53.7M | $134.6M | ||
| Q2 24 | $49.0M | $143.5M |
| Q1 26 | 37.1% | 62.9% | ||
| Q4 25 | 36.6% | 62.9% | ||
| Q3 25 | 37.7% | 60.5% | ||
| Q2 25 | 38.5% | 59.5% | ||
| Q1 25 | 39.3% | 56.9% | ||
| Q4 24 | 37.5% | 58.9% | ||
| Q3 24 | 37.3% | 59.7% | ||
| Q2 24 | 37.5% | 62.4% |
| Q1 26 | 11.2% | 25.6% | ||
| Q4 25 | 12.2% | 25.6% | ||
| Q3 25 | 10.9% | 20.1% | ||
| Q2 25 | 11.8% | 18.4% | ||
| Q1 25 | 11.6% | 12.9% | ||
| Q4 24 | 10.4% | 17.0% | ||
| Q3 24 | 11.5% | 15.3% | ||
| Q2 24 | 11.4% | 15.7% |
| Q1 26 | 7.3% | 21.2% | ||
| Q4 25 | 9.4% | 21.2% | ||
| Q3 25 | 8.1% | 23.5% | ||
| Q2 25 | 9.1% | 15.5% | ||
| Q1 25 | 8.3% | 10.2% | ||
| Q4 24 | 8.8% | 13.6% | ||
| Q3 24 | 8.2% | 13.5% | ||
| Q2 24 | 8.1% | 14.3% |
| Q1 26 | $1.30 | $0.67 | ||
| Q4 25 | $1.70 | $0.67 | ||
| Q3 25 | $1.41 | $0.70 | ||
| Q2 25 | $1.53 | $0.45 | ||
| Q1 25 | $1.27 | $0.27 | ||
| Q4 24 | $1.41 | $0.37 | ||
| Q3 24 | $1.30 | $0.34 | ||
| Q2 24 | $1.19 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $272.2M | $917.7M |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $1.3B | $2.7B |
| Total Assets | — | $6.3B |
| Debt / EquityLower = less leverage | 0.98× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $272.2M | $917.7M | ||
| Q4 25 | $389.9M | $917.7M | ||
| Q3 25 | $314.3M | $1.8B | ||
| Q2 25 | $301.5M | $1.2B | ||
| Q1 25 | $259.0M | $904.9M | ||
| Q4 24 | $370.3M | $606.1M | ||
| Q3 24 | $323.0M | $621.2M | ||
| Q2 24 | $564.8M | $939.2M |
| Q1 26 | $1.3B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.3B | $2.7B | ||
| Q4 25 | $1.3B | $2.7B | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.2B | $2.3B | ||
| Q4 24 | $1.3B | $2.1B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.4B |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $3.5B | $6.3B | ||
| Q3 25 | $3.4B | $7.5B | ||
| Q2 25 | $3.4B | $7.3B | ||
| Q1 25 | $3.3B | $6.8B | ||
| Q4 24 | $3.3B | $6.5B | ||
| Q3 24 | $3.3B | $6.4B | ||
| Q2 24 | $3.5B | $6.8B |
| Q1 26 | 0.98× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $-63.1M | — |
| FCF MarginFCF / Revenue | -9.1% | — |
| Capex IntensityCapex / Revenue | 6.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $180.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $160.4M | $294.0M | ||
| Q3 25 | $105.0M | $659.9M | ||
| Q2 25 | $82.0M | $303.0M | ||
| Q1 25 | $7.4M | $183.8M | ||
| Q4 24 | $174.7M | $301.4M | ||
| Q3 24 | $91.7M | $199.5M | ||
| Q2 24 | $83.0M | $279.4M |
| Q1 26 | $-63.1M | — | ||
| Q4 25 | $121.3M | $192.1M | ||
| Q3 25 | $65.3M | $579.4M | ||
| Q2 25 | $56.9M | $208.9M | ||
| Q1 25 | $-24.8M | $96.8M | ||
| Q4 24 | $116.4M | $176.8M | ||
| Q3 24 | $67.2M | $88.3M | ||
| Q2 24 | $61.0M | $213.3M |
| Q1 26 | -9.1% | — | ||
| Q4 25 | 16.8% | 15.3% | ||
| Q3 25 | 9.4% | 47.9% | ||
| Q2 25 | 8.5% | 18.1% | ||
| Q1 25 | -4.0% | 9.3% | ||
| Q4 24 | 17.5% | 15.9% | ||
| Q3 24 | 10.3% | 8.9% | ||
| Q2 24 | 10.1% | 21.2% |
| Q1 26 | 6.4% | — | ||
| Q4 25 | 5.4% | 8.1% | ||
| Q3 25 | 5.7% | 6.7% | ||
| Q2 25 | 3.7% | 8.1% | ||
| Q1 25 | 5.2% | 8.4% | ||
| Q4 24 | 8.8% | 11.2% | ||
| Q3 24 | 3.7% | 11.2% | ||
| Q2 24 | 3.6% | 6.6% |
| Q1 26 | — | — | ||
| Q4 25 | 2.36× | 1.10× | ||
| Q3 25 | 1.85× | 2.33× | ||
| Q2 25 | 1.34× | 1.69× | ||
| Q1 25 | 0.14× | 1.74× | ||
| Q4 24 | 2.99× | 1.99× | ||
| Q3 24 | 1.71× | 1.48× | ||
| Q2 24 | 1.69× | 1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
